This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Measurement Specialties Announces Results For The Third Quarter Ended December 31, 2012

Stocks in this article: MEAS

HAMPTON, Va., Feb. 5, 2013 (GLOBE NEWSWIRE) -- Measurement Specialties, Inc. (Nasdaq:MEAS) (the "Company"), a global designer and manufacturer of sensors and sensor-based systems, announces results for the three and nine months ended December 31, 2012.

The Company reported consolidated net sales of $81.6 million for the three months ended December 31, 2012, an increase of $5.3 million or 7%, as compared to the corresponding period of last year. Excluding sales attributed to the Gentech, Cosense and RTD acquisitions of approximately $8.1 million for the three months ended December 31, 2012 and net sales of approximately $2.5 million for Gentech during the prior year, organic sales decreased $0.3 million or approximately 0.4%. Changes in the average U.S. dollar / Euro exchange rate during the three months ended December 31, 2012 as compared to the three months ended December 31, 2011, adversely impacted the Company's organic sales by approximately $0.7 million.

For the three months ended December 31, 2012, the Company reported net income of $6.1 million, or $0.38 per diluted share, as compared to net income of $4.7 million, or $0.30 per diluted share, for the same period last year.

The Company reported consolidated net sales of $258.0 million for the nine months ended December 31, 2012, an increase of $31.2 million or 13.8%, as compared to the corresponding period of last year. Excluding sales attributed to the Eureka, Celesco, Gentech, Cosense and RTD acquisitions of $32.5 million for the nine months ended December 31, 2012, and sales of $7.3 million attributed to Eureka, Celesco and Gentech for the nine months ended December 31, 2011, organic sales increased approximately $6.0 million or 2.7%. Changes in the average U.S. dollar / Euro exchange rate during the nine months ended December 31, 2012 as compared to the nine months ended December 31, 2011, adversely impacted the Company's organic sales by approximately $5.2 million.

1 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs